Table 2.

Comparison of Patients who Chose Treatment and Observation by Prostate Cancer-Related and Health Factors

FactorsOverall (n [%])Treatment (n [%])Observation (n [%])P*
Gleason Graden = 184n = 161N = 23
    2–40 (0.0)0 (0.0)0 (0.0)
    5–6103 (55.9)84 (52.1)19 (82.6)
    762 (33.7)60 (37.3)2 (8.7)
    8–1019 (10.3)17 (10.6)2 (8.7)0.02
    Mean ± SD6.6 ± 0.76.6 ± 0.76.2 ± 0.70.02
Prostate-specific antigen testn = 183n = 161n = 23
    ≤10159 (86.9)139 (86.3)21 (91.3)
    >1024 (13.1)22 (13.7)2 (8.7)0.74
    Mean ± SD6.7 ± 5.36.8 ± 5.55.6 ± 3.40.14
Life expectancy by age (years)n = 183n = 160N = 23
    <104 (2.2)2 (1.3)2 (8.7)
    10–20104 (56.8)86 (53.8)18 (78.3)
    ≥2075 (40.9)72 (45.0)3 (13.0)0.002*
Comorbidity scoren = 184n = 161N = 23
    074 (40.2)66 (40.9)8 (34.8)
    175 (40.8)67 (41.6)8 (34.8)
    227 (14.7)23 (14.3)4 (17.4)
    ≥38 (4.4)5 (3.1)3 (13.0)0.16
    Mean ± SD0.9 ± 1.00.83 ± 0.961.26 ± 1.50.18
Short Form-36 subscales
    Physical component summaryn = 142n = 134n = 8
        Mean ± SD54.5 ± 7.654.5 ± 7.252.6 ± 12.30.66
    Mental component summaryn = 142n = 134n = 8
        Mean ± SD44.1 ± 6.843.9 ± 6.946.4 ± 4.50.29
Prostate cancer index
    Urinaryn = 141n = 132n = 9
        Mean ± SD90.2 ± 16.990.1 ± 17.491.3 ± 9.30.83
    Boweln = 142n = 133n = 9
        Mean ± SD88.8 ± 12.588.5 ± 12.892.9 ± 4.50.03
    Sexualn = 137n = 128n = 9
        Mean ± SD57.7 ± 29.957.8 ± 30.455.4 ± 23.80.82
    Urinary Bothern = 144n = 135n = 9
        Mean ± SD86.1 ± 23.085.9 ± 23.488.9 ± 18.20.71
    Bowel Bothern = 144n = 135n = 9
        Mean ± SD92.5 ± 17.592.0 ± 17.9100 ± 0.0<0.0001
    Sexual Bothern = 142n = 133n = 9
        Mean ± SD65.8 ± 36.865.4 ± 36.872.2 ± 38.40.59
Fear of cancer recurrencen = 141n = 133n = 8
    Mean ± SD10.7 ± 3.810.7 ± 3.710.9 ± 4.50.92